Special Reports

The Special Report, "Clinical Pathways to Address the Challenges of Treatment Resistance and Relapse in Multiple Myeloma," reviews the challenges associated with different phases of treatment for multiple myeloma and how clinical pathways can support physicians’ decision-making.
The Special Report, "Clinical Pathways to Address the Challenges of Treatment Resistance and Relapse in Multiple Myeloma," reviews the challenges associated with different phases of treatment for multiple myeloma and how clinical pathways can support physicians’ decision-making.
The final section of the special report speculates on the future treatment landscape for relapsed or refractory multiple myeloma.
The fourth section of the report reviews the economic implications of a multiple myeloma diagnosis.
The next section of the report analyzes the process of including evidence-based treatment decision making into clinical pathways for multiple myeloma.
The second section of the report explores the challenges of treatment resistance and relapse in multiple myeloma.
This report reviews the complex nature of multiple myeloma treatment, the current landscape of clinical practice guidelines and treatment pathways, and economic considerations for treatment.